Search - tctmd.com

Displaying 581 - 600 of 807

Presentation TCT 2013

Gender Differences in Patients with Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation

Presenter: Stefan Stortecky, Peter Wenaweser, Thomas Pilgrim, Alexander Kadner, Lutz Buellesfeld, Christoph Huber, Ahmed Khattab, Stephan Windecker

January 31, 2013

Presentation TCT 2013

Epidemiology of Severe Aortic Stenosis in the Elderly: A Systematic Review and Meta-Analysis of Published Prevalence Estimates

Presenter: Liesl Strachan, Ruben L. J. Osnabrugge, Rachele Busca, Pascale Brasseur, Corinne Le Reun

January 31, 2013

Presentation TCT 2013

Clinical Outcome Of Patients With Paradoxical Low-Flow, Low-Gradient Aortic Stenosis After Transcatheter Aortic Valve Implantation.

Presenter: Jury Schewel, Dimitry Schewel, Christian Frerker, Thomas Thielsen, Felix Meinke, Felix Kreidel, Karl-Heinz Kuck, Ulrich Sch?fer

January 31, 2013

Presentation TCT 2013

Clinical Outcome Of Patients With Low-Flow, Low-Gradient Aortic Stenosis After Transcatheter Aortic Valve Implantation.

Presenter: Jury Schewel, Dimitry Schewel, Christian Frerker, Thomas Thielsen, Felix Meinke, Felix Kreidel, Karl-Heinz Kuck, Ulrich Sch?fer

January 31, 2013

News Daily News

STS Meeting Looks at New TAVR Device and Reviews Valve Procedure Rates in the UK

Jason Kahn

January 28, 2013

News Daily News

Year in Review: Physicians Highlight the Most Important Interventional News of 2012

Caitlin E. Cox

January 02, 2013

News Daily News

‘Top Ten’ Advances of 2012 Highlighted by AHA-ASA, ACC

Caitlin E. Cox

December 26, 2012

News Daily News

Un IMC Bajo Predice los ACV y la Muerte tras una TAVR

November 28, 2012

News Daily News

Low BMI Predicts Stroke, Death After TAVR

November 28, 2012

Presentation

Predictors of Clinical Outcomes in Patients with Severe Aortic Stenosis Undergoing TAVR

Presenter: T. Pilgrim

November 27, 2012

News Industry News

First U.S. Patient Treated in Medtronic Clinical Trial Evaluating CoreValve® System in Intermediate-Risk Patients

November 15, 2012

News Daily News

Transfemoral—But Not Transapical—TAVR More Cost-Effective Than Surgery

Caitlin E. Cox

November 12, 2012

News Daily News

La TAVR Transfemoral, no la Transapical es Más Rentable que la Cirugía

Caitlin E. Cox

November 12, 2012

Presentation

Cost-Effectiveness of TAVR vs. Surgical Aortic Valve Replacement in High-Risk Patients with Severe Aortic Stenosis

Presenter: M.R. Reynolds

November 08, 2012

News Conference News TCT 2012

TAVR Feasible for Inoperable Patients with Severe Regurgitation Alone

October 31, 2012

News Industry News

First Results from Medtronic Engager™ European Pivotal Trial Demonstrate Positive Outcomes

October 29, 2012

News Conference News TCT 2012

Type of Vascular Access Not Linked to Silent Cerebral Infarcts

October 25, 2012

News Conference News TCT 2012

PARTNER: Benefits of TAVR Sustained Out to 3 Years

October 25, 2012

News Industry News

Survival Benefit With Edwards SAPIEN Valve Widens Further at Three Years

October 24, 2012

News Industry News

Study Confirms Benefits of Transcatheter Aortic Valve Replacement Over Three Years

October 24, 2012

Advertisement

Gender Differences in Patients with Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation

Epidemiology of Severe Aortic Stenosis in the Elderly: A Systematic Review and Meta-Analysis of Published Prevalence Estimates

Clinical Outcome Of Patients With Paradoxical Low-Flow, Low-Gradient Aortic Stenosis After Transcatheter Aortic Valve Implantation.

Clinical Outcome Of Patients With Low-Flow, Low-Gradient Aortic Stenosis After Transcatheter Aortic Valve Implantation.

STS Meeting Looks at New TAVR Device and Reviews Valve Procedure Rates in the UK

Year in Review: Physicians Highlight the Most Important Interventional News of 2012

‘Top Ten’ Advances of 2012 Highlighted by AHA-ASA, ACC

Un IMC Bajo Predice los ACV y la Muerte tras una TAVR

Low BMI Predicts Stroke, Death After TAVR

Predictors of Clinical Outcomes in Patients with Severe Aortic Stenosis Undergoing TAVR

First U.S. Patient Treated in Medtronic Clinical Trial Evaluating CoreValve® System in Intermediate-Risk Patients

Transfemoral—But Not Transapical—TAVR More Cost-Effective Than Surgery

La TAVR Transfemoral, no la Transapical es Más Rentable que la Cirugía

Cost-Effectiveness of TAVR vs. Surgical Aortic Valve Replacement in High-Risk Patients with Severe Aortic Stenosis

TAVR Feasible for Inoperable Patients with Severe Regurgitation Alone

First Results from Medtronic Engager™ European Pivotal Trial Demonstrate Positive Outcomes

Type of Vascular Access Not Linked to Silent Cerebral Infarcts

PARTNER: Benefits of TAVR Sustained Out to 3 Years

Survival Benefit With Edwards SAPIEN Valve Widens Further at Three Years

Study Confirms Benefits of Transcatheter Aortic Valve Replacement Over Three Years

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content